Vera Therapeutics, Inc
NASDAQ:VERA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vera Therapeutics, Inc
NASDAQ:VERA
|
US |
|
B
|
Brunswick Corp
XMUN:BWI
|
US |
|
A
|
Areeya Property PCL
SET:A
|
TH |
Intrinsic Value
The intrinsic value of Vera Therapeutics, Inc (VERA) under the Base Case is 3.85 USD per share.
Compared with the current market price of 27.69 USD, the stock appears
Overvalued by 86% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Vera Therapeutics Does
Vera Therapeutics is a biotechnology company focused on medicines for immune-driven kidney diseases, especially IgA nephropathy. It develops drug candidates that try to calm the harmful immune activity that damages the kidneys, with its lead program centered on atacicept. The company does not sell consumer products; it is building a pipeline of prescription therapies and advancing them through clinical testing and regulatory review.
- Headquarters
- United States of America US
- Employees
- 249
- IPO date
- May 14, 2021
Earnings Waterfall
Vera Therapeutics, Inc
The intrinsic value for Vera Therapeutics, Inc (VERA) under the Base Case is 3.85 USD.
Compared with the current market price of 27.69 USD, the stock appears Overvalued by 86% .